Compugen (CGEN) Competitors $1.65 +0.07 (+4.43%) (As of 12/6/2024 06:03 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends CGEN vs. PRTC, MGTX, YMAB, ZVRA, TERN, DNA, SIGA, ARCT, ORGO, and XERSShould you be buying Compugen stock or one of its competitors? The main competitors of Compugen include PureTech Health (PRTC), MeiraGTx (MGTX), Y-mAbs Therapeutics (YMAB), Zevra Therapeutics (ZVRA), Terns Pharmaceuticals (TERN), Ginkgo Bioworks (DNA), SIGA Technologies (SIGA), Arcturus Therapeutics (ARCT), Organogenesis (ORGO), and Xeris Biopharma (XERS). These companies are all part of the "pharmaceutical products" industry. Compugen vs. PureTech Health MeiraGTx Y-mAbs Therapeutics Zevra Therapeutics Terns Pharmaceuticals Ginkgo Bioworks SIGA Technologies Arcturus Therapeutics Organogenesis Xeris Biopharma PureTech Health (NASDAQ:PRTC) and Compugen (NASDAQ:CGEN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, community ranking, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership. Do institutionals and insiders believe in PRTC or CGEN? 0.0% of PureTech Health shares are owned by institutional investors. Comparatively, 12.2% of Compugen shares are owned by institutional investors. 5.3% of PureTech Health shares are owned by company insiders. Comparatively, 9.5% of Compugen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts recommend PRTC or CGEN? PureTech Health currently has a consensus price target of $45.00, suggesting a potential upside of 103.62%. Compugen has a consensus price target of $4.00, suggesting a potential upside of 142.42%. Given Compugen's higher possible upside, analysts plainly believe Compugen is more favorable than PureTech Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Compugen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings and valuation, PRTC or CGEN? Compugen has higher revenue and earnings than PureTech Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPureTech Health$3.33M158.89-$65.70MN/AN/ACompugen$33.46M4.40-$18.75M$0.0282.50 Does the MarketBeat Community favor PRTC or CGEN? Compugen received 299 more outperform votes than PureTech Health when rated by MarketBeat users. Likewise, 64.30% of users gave Compugen an outperform vote while only 45.00% of users gave PureTech Health an outperform vote. CompanyUnderperformOutperformPureTech HealthOutperform Votes945.00% Underperform Votes1155.00% CompugenOutperform Votes30864.30% Underperform Votes17135.70% Does the media favor PRTC or CGEN? In the previous week, PureTech Health had 1 more articles in the media than Compugen. MarketBeat recorded 1 mentions for PureTech Health and 0 mentions for Compugen. PureTech Health's average media sentiment score of 1.16 beat Compugen's score of 0.00 indicating that PureTech Health is being referred to more favorably in the media. Company Overall Sentiment PureTech Health Positive Compugen Neutral Is PRTC or CGEN more profitable? Compugen has a net margin of 2.67% compared to PureTech Health's net margin of 0.00%. Compugen's return on equity of 2.62% beat PureTech Health's return on equity.Company Net Margins Return on Equity Return on Assets PureTech HealthN/A N/A N/A Compugen 2.67%2.62%1.36% Which has more risk and volatility, PRTC or CGEN? PureTech Health has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, Compugen has a beta of 2.59, indicating that its share price is 159% more volatile than the S&P 500. SummaryCompugen beats PureTech Health on 12 of the 17 factors compared between the two stocks. Ad Porter & CompanyFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CGEN vs. The Competition Export to ExcelMetricCompugenBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$141.89M$3.07B$5.29B$8.37BDividend YieldN/A1.85%5.73%4.02%P/E Ratio82.5043.50101.5017.49Price / Sales4.40308.351,249.1591.32Price / CashN/A175.2743.5738.70Price / Book2.263.994.864.98Net Income-$18.75M-$41.34M$120.83M$198.24M7 Day Performance3.77%-0.46%0.55%0.80%1 Month Performance-7.30%-0.96%-0.15%4.98%1 Year Performance95.82%32.24%33.42%29.77% Compugen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CGENCompugen1.5959 of 5 stars$1.65+4.4%$4.00+142.4%+104.7%$141.89M$33.46M82.5068PRTCPureTech Health2.0722 of 5 stars$22.00-0.9%$45.00+104.5%+29.4%$526.68M$3.33M0.00100News CoverageGap DownMGTXMeiraGTx4.6004 of 5 stars$6.70-1.0%$23.50+250.7%+25.6%$523.61M$14.02M-5.60300Positive NewsYMABY-mAbs Therapeutics3.8954 of 5 stars$11.58-2.9%$21.38+84.6%+53.9%$518.67M$84.82M-22.07150Analyst UpgradeAnalyst RevisionNews CoverageZVRAZevra Therapeutics3.1305 of 5 stars$9.71+4.1%$21.00+116.3%+78.0%$518.28M$24.49M-4.7465TERNTerns Pharmaceuticals4.548 of 5 stars$6.07-2.7%$30.70+405.8%-3.8%$515.58M$1M-5.2940Analyst ForecastNews CoverageDNAGinkgo Bioworks0.8159 of 5 stars$8.89+2.2%$4.58-48.5%N/A$510.99M$217.11M-0.671,218Options VolumeSIGASIGA Technologies2.3199 of 5 stars$7.13-2.1%N/A+18.2%$509.12M$173.73M6.0740ARCTArcturus Therapeutics3.0145 of 5 stars$18.69+1.9%$71.40+282.0%-20.5%$506.31M$169.93M-8.26180Positive NewsORGOOrganogenesis3.4778 of 5 stars$3.81-1.6%$5.33+40.0%+31.0%$505.13M$433.14M-64.50950XERSXeris Biopharma4.0542 of 5 stars$3.37+2.7%$4.87+44.4%+89.2%$502.40M$163.91M-7.51290Positive News Related Companies and Tools Related Companies PureTech Health Alternatives MeiraGTx Alternatives Y-mAbs Therapeutics Alternatives Zevra Therapeutics Alternatives Terns Pharmaceuticals Alternatives Ginkgo Bioworks Alternatives SIGA Technologies Alternatives Arcturus Therapeutics Alternatives Organogenesis Alternatives Xeris Biopharma Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CGEN) was last updated on 12/8/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredExpert: The most important message you’ll see in 2024The message I'm sharing today could be the most important message of 2024. In short, America is being invad...The Freeport Society | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredUrgent warning about your moneyThe stock market is booming … And Bitcoin just hiked through the roof. But don't get fooled by the "good...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compugen Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compugen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
